229 related articles for article (PubMed ID: 32393472)
1. Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Luo L; Guan X; Begum G; Ding D; Gayden J; Hasan MN; Fiesler VM; Dodelson J; Kohanbash G; Hu B; Amankulor NM; Jia W; Castro MG; Sun B; Sun D
Mol Cancer Ther; 2020 Jul; 19(7):1550-1561. PubMed ID: 32393472
[TBL] [Abstract][Full Text] [Related]
2. WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration.
Zhu W; Begum G; Pointer K; Clark PA; Yang SS; Lin SH; Kahle KT; Kuo JS; Sun D
Mol Cancer; 2014 Feb; 13():31. PubMed ID: 24555568
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells.
Algharabil J; Kintner DB; Wang Q; Begum G; Clark PA; Yang SS; Lin SH; Kahle KT; Kuo JS; Sun D
Cell Physiol Biochem; 2012; 30(1):33-48. PubMed ID: 22759954
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
5. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
6. Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy.
Guan X; Hasan MN; Begum G; Kohanbash G; Carney KE; Pigott VM; Persson AI; Castro MG; Jia W; Sun D
Cell Death Dis; 2018 Sep; 9(10):1010. PubMed ID: 30262908
[TBL] [Abstract][Full Text] [Related]
7. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
8. Role of NKCC1 Activity in Glioma K
Luo L; Wang J; Ding D; Hasan MN; Yang SS; Lin SH; Schreppel P; Sun B; Yin Y; Erker T; Sun D
Front Physiol; 2020; 11():911. PubMed ID: 32848856
[No Abstract] [Full Text] [Related]
9. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
10. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis.
Pandey V; Ranjan N; Narne P; Babu PP
Sci Rep; 2019 Mar; 9(1):5012. PubMed ID: 30899038
[TBL] [Abstract][Full Text] [Related]
11. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.
Haas BR; Sontheimer H
Cancer Res; 2010 Jul; 70(13):5597-606. PubMed ID: 20570904
[TBL] [Abstract][Full Text] [Related]
14. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation.
Garzon-Muvdi T; Schiapparelli P; ap Rhys C; Guerrero-Cazares H; Smith C; Kim DH; Kone L; Farber H; Lee DY; An SS; Levchenko A; Quiñones-Hinojosa A
PLoS Biol; 2012; 10(5):e1001320. PubMed ID: 22570591
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
16. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
17. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
18. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
19. Imaging temozolomide-induced changes in the myeloid glioma microenvironment.
Foray C; Valtorta S; Barca C; Winkeler A; Roll W; Müther M; Wagner S; Gardner ML; Hermann S; Schäfers M; Grauer OM; Moresco RM; Zinnhardt B; Jacobs AH
Theranostics; 2021; 11(5):2020-2033. PubMed ID: 33500706
[No Abstract] [Full Text] [Related]
20. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
